|
Unified Business No. |
52625245 |
|
Registration Status |
|
Equity Status |
Overseas and Foreign Investment |
|
Company Name |
安立璽榮生醫股份有限公司 |
|
Foreign Company Name as specified in the Charter |
ELIXIRON IMMUNOTHERAPEUTICS INC. |
|
Amount of Capital (NT$) |
550,000,000 |
|
Total Paid-in Capital (NT$) |
473,880,000 |
|
Share Value (NT$) |
10 |
|
Equity Amount (Shares) |
47,388,000 |
|
Name of Representative |
HUNG-KAI CHEN |
|
Location of Company |
16F-3, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011, Taiwan (R.O.C.) |
|
Registration Authority |
Taipei City Government |
|
Date of Registration |
2017/03/30 |
|
Last Modification Date |
2024/05/15 |
|
Special voting rights |
N |
|
Special shares with veto for specific issues |
N |
|
The right of a special shareholder to be |
N |
|
Business Scope |
G01010 Biotechnology Services |
|
Unified Business No. |
|
52625245 |
|
Registration Status |
|
Equity Status |
|
Overseas and Foreign Investment |
|
Company Name |
|
安立璽榮生醫股份有限公司 |
|
Foreign Company Name as specified in the Charter |
|
ELIXIRON IMMUNOTHERAPEUTICS INC. |
|
Amount of Capital (NT$) |
|
550,000,000 |
|
Total Paid-in Capital (NT$) |
|
473,880,000 |
|
Share Value (NT$) |
|
10 |
|
Equity Amount (Shares) |
|
47,388,000 |
|
Name of Representative |
|
HUNG-KAI CHEN |
|
Location of Company |
|
16F-3, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011, Taiwan (R.O.C.) |
|
Registration Authority |
|
Taipei City Government |
|
Date of Registration |
|
2017/03/30 |
|
Last Modification Date |
|
2024/05/15 |
|
Special voting rights |
|
N |
|
Special shares with veto for specific issues |
|
N |
|
The right of a special shareholder to be elected as a director or supervisor is prohibited or restricted or elected to a certain number of places |
|
N |
|
Business Scope |
|
G01010 Biotechnology Services |
